Get started
Author

Longshan Zhang

Observed names: Zhang Longshan, Zhang, Longshan
ORCID: 0009-0003-1803-5957
Observed ORCID: 0009-0003-1803-5957
OpenAlex ID: A5040499816
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma
2022 · Mi Yang, Xixi Wu, et al. · Journal of Hepatology · 243
PDF
Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway
2021 · Weiqiang Huang, Longshan Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 105
PDF
Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis
2019 · Mi Yang, Weiqiang Huang, et al. · British Journal of Cancer · 49
PDF
Interferon-Induced Protein 44 Correlated With Immune Infiltration Serves as a Potential Prognostic Indicator in Head and Neck Squamous Cell Carcinoma
2020 · Hua Pan, Xiaoqing Wang, et al. · Frontiers in Oncology · 36
PDF
Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways
2022 · Jin Lan, Jingzhan Huang, et al. · Journal of Cellular and Molecular Medicine · 28
SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma
2021 · Lu Yuan, Xixi Wu, et al. · Cancer Immunology Immunotherapy · 27
PDF
Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human
2019 · Yao Fan, Longshan Zhang, et al. · Cancer Gene Therapy · 24
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
2021 · Mi Yang, Xixi Wu, et al. · Clinical and Translational Medicine · 23
PDF
Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors
2020 · Longshan Zhang, Yao Fan, et al. · Frontiers in Oncology · 16
PDF
Expression profile of SYNE3 and bioinformatic analysis of its prognostic value and functions in tumors
2020 · Liwei Liao, Longshan Zhang, et al. · Journal of Translational Medicine · 12
PDF
Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al. · Clinical Cancer Research · 11
The development of a novel zeolite-based assay for efficient and deep plasma proteomic profiling
2024 · Nan Li, Jingnan Huang, et al. · Journal of Nanobiotechnology · 10
PDF
CLIC4 regulates radioresistance of nasopharyngeal carcinoma by iNOS after γ-rays but not carbon ions irradiation.
2020 · Lin Zhu, Qianping Chen, et al. · PubMed · 8
PDF
VLDL and LDL Subfractions Enhance the Risk Stratification of Individuals Who Underwent Epstein–Barr Virus‐Based Screening for Nasopharyngeal Carcinoma: A Multicenter Cohort Study
2024 · Zhenhua Zhou, Tingxi Tang, et al. · Advanced Science · 6
PDF
Exploring prognostic value and regulation network of PPP1R1A in hepatocellular carcinoma
2022 · Xixi Wu, Yin Wang, et al. · Human Cell · 3
Correction to: Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway
2021 · Weiqiang Huang, Longshan Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 3
PDF
SAA1 and metabolomic signatures predict hyperprogression with immunotherapy in pan cancers
2024 · Xiaoqing Wang, Longshan Zhang, et al. · Clinical and Translational Medicine · 2
DFNA5 attenuated in head and neck squamous cell carcinoma acquired with radio-resistance and associated with PD-L2
2020 · Weiqiang Huang, Lu Yuan, et al. · 1
PDF
Corrigendum to: “COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma” [J Hepatol (2022) 76(5):1138-1150; 10.1016/j.jhep.2022.01.009)
2026 · Mi Yang, Xixi Wu, et al. · Journal of Hepatology
PDF
Data from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Data from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Supplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Supplementary Figure S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Supplementary Figure S2 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Supplementary Materials S1 from Plasma Metabolic Profiles-Based Prediction of Induction Chemotherapy Efficacy in Nasopharyngeal Carcinoma: Results of a Bidirectional Clinical Trial
2024 · Tingxi Tang, Zhenhua Zhou, et al.
Works count: 66
Citation count: 607
H-index: 11
I10-index: 12
Year
Topic
Type